logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 14
  • 1
    Thornal, Kevin Royce
    Ceo born in December 1973
    Individual (1 offspring)
    Officer
    2023-07-03 ~ 2025-04-03
    OF - Director → CIF 0
  • 2
    Macleod, Roderick Henry
    Chief Financial Officer born in October 1966
    Individual (1 offspring)
    Officer
    2020-06-15 ~ 2025-06-18
    OF - Director → CIF 0
  • 3
    Williams, Anthony Lamar
    Born in March 1971
    Individual (1 offspring)
    Officer
    2025-05-01 ~ now
    OF - Director → CIF 0
  • 4
    Rashid, Kashif
    General Counsel born in July 1973
    Individual (2 offsprings)
    Officer
    2018-09-10 ~ 2025-04-03
    OF - Director → CIF 0
  • 5
    Kline, Kyle Richard
    Born in January 1985
    Individual (3 offsprings)
    Officer
    2025-05-01 ~ now
    OF - Director → CIF 0
  • 6
    Galligan, Andrew Hugh
    Cfo born in July 1956
    Individual (2 offsprings)
    Officer
    2010-07-22 ~ 2020-06-15
    OF - Director → CIF 0
  • 7
    Grossman, Donald Keith
    President And Ceo born in May 1960
    Individual (2 offsprings)
    Officer
    2019-03-20 ~ 2023-04-24
    OF - Director → CIF 0
  • 8
    Elghandour, Rami
    President And Ceo born in December 1978
    Individual (1 offspring)
    Officer
    2014-02-25 ~ 2019-03-19
    OF - Director → CIF 0
  • 9
    Walker, Andre Byron
    Director born in December 1963
    Individual (1 offspring)
    Officer
    2010-07-22 ~ 2014-02-25
    OF - Director → CIF 0
  • 10
    Austin, Richard
    Accountant born in December 1971
    Individual (5 offsprings)
    Officer
    2010-05-28 ~ 2010-07-22
    OF - Director → CIF 0
  • 11
    Alataris, Konstantinos
    Director born in March 1970
    Individual (1 offspring)
    Officer
    2010-07-22 ~ 2011-03-22
    OF - Director → CIF 0
    2012-09-12 ~ 2014-02-25
    OF - Director → CIF 0
  • 12
    2560, General Armistead Avenue, Audubon, Pennsylvania, United States
    Corporate (3 offsprings)
    Person with significant control
    2025-04-03 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 13
    CROWE U.K. LLP - now OC307043 10887534... (more)
    CROWE CLARK WHITEHILL LLP
    - 2018-06-25 OC307043 10887534... (more)
    HORWATH CLARK WHITEHILL LLP - 2010-10-01 OC307043 01237646... (more)
    Carrick House, Lypiatt Road, Cheltenham, Gloucestershire
    Active Corporate (213 parents, 48 offsprings)
    Officer
    2010-05-28 ~ 2019-03-22
    OF - Secretary → CIF 0
  • 14
    1800, Bridge Parkway, Redwood City, Ca 94065, United States
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ 2025-04-03
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

NEVRO MEDICAL LIMITED

Period: 2010-05-28 ~ now
Company number: 07268550
Registered name
NEVRO MEDICAL LIMITED - now
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
12024-01-01 ~ 2024-12-31
Turnover/Revenue
19,029,392 GBP2024-01-01 ~ 2024-12-31
18,643,196 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
6,460,258 GBP2024-01-01 ~ 2024-12-31
7,530,680 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
12,569,134 GBP2024-01-01 ~ 2024-12-31
11,112,516 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
12,187,707 GBP2024-01-01 ~ 2024-12-31
10,649,109 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
381,427 GBP2024-01-01 ~ 2024-12-31
463,407 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
20,724 GBP2024-01-01 ~ 2024-12-31
Interest Payable/Similar Charges (Finance Costs)
2,895 GBP2024-01-01 ~ 2024-12-31
7,055 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
399,256 GBP2024-01-01 ~ 2024-12-31
456,352 GBP2023-01-01 ~ 2023-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
401,817 GBP2024-01-01 ~ 2024-12-31
265,260 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-2,561 GBP2024-01-01 ~ 2024-12-31
191,092 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
-2,561 GBP2024-01-01 ~ 2024-12-31
191,092 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
3,224 GBP2023-12-31
Fixed Assets - Investments
31,899 GBP2024-12-31
31,899 GBP2023-12-31
Fixed Assets
31,899 GBP2024-12-31
35,123 GBP2023-12-31
Total Inventories
730,429 GBP2024-12-31
886,275 GBP2023-12-31
Debtors
8,852,309 GBP2024-12-31
12,625,027 GBP2023-12-31
Cash at bank and in hand
8,016,952 GBP2024-12-31
2,408,533 GBP2023-12-31
Current Assets
17,599,690 GBP2024-12-31
15,919,835 GBP2023-12-31
Creditors
Current
1,597,678 GBP2024-12-31
1,351,715 GBP2023-12-31
Net Current Assets/Liabilities
16,002,012 GBP2024-12-31
14,568,120 GBP2023-12-31
Total Assets Less Current Liabilities
16,033,911 GBP2024-12-31
14,603,243 GBP2023-12-31
Equity
Called up share capital
1,000 GBP2024-12-31
1,000 GBP2023-12-31
1,000 GBP2022-12-31
Retained earnings (accumulated losses)
8,475,087 GBP2024-12-31
8,477,648 GBP2023-12-31
8,286,556 GBP2022-12-31
Equity
16,033,911 GBP2024-12-31
14,603,243 GBP2023-12-31
13,430,690 GBP2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-2,561 GBP2024-01-01 ~ 2024-12-31
Wages/Salaries
6,076,107 GBP2024-01-01 ~ 2024-12-31
5,717,999 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
895,815 GBP2024-01-01 ~ 2024-12-31
828,408 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
466,422 GBP2024-01-01 ~ 2024-12-31
284,960 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
7,438,344 GBP2024-01-01 ~ 2024-12-31
6,831,367 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
552024-01-01 ~ 2024-12-31
532023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
3,224 GBP2024-01-01 ~ 2024-12-31
17,560 GBP2023-01-01 ~ 2023-12-31
Current Tax for the Period
402,705 GBP2024-01-01 ~ 2024-12-31
270,336 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
99,814 GBP2024-01-01 ~ 2024-12-31
107,334 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Computers
246,377 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
246,377 GBP2024-12-31
243,153 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
3,224 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Computers
3,224 GBP2023-12-31
Investments in Group Undertakings
Cost valuation
31,899 GBP2023-12-31
Investments in Group Undertakings
31,899 GBP2024-12-31
31,899 GBP2023-12-31
Raw Materials
730,429 GBP2024-12-31
886,275 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
1,451,723 GBP2024-12-31
2,652,453 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
6,816,523 GBP2024-12-31
9,258,280 GBP2023-12-31
Other Debtors
Current
580,420 GBP2024-12-31
711,539 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
3,643 GBP2024-12-31
2,755 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
8,852,309 GBP2024-12-31
12,625,027 GBP2023-12-31
Trade Creditors/Trade Payables
Current
168,852 GBP2024-12-31
6,021 GBP2023-12-31
Amounts owed to group undertakings
Current
64,725 GBP2024-12-31
64,791 GBP2023-12-31
Corporation Tax Payable
Current
169,658 GBP2024-12-31
229,622 GBP2023-12-31
Other Taxation & Social Security Payable
Current
303,666 GBP2024-12-31
300,918 GBP2023-12-31
Other Creditors
Current
890,777 GBP2024-12-31
750,363 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
110,646 GBP2024-12-31
123,482 GBP2023-12-31
Between one and five year
152,565 GBP2024-12-31
61,733 GBP2023-12-31
All periods
263,211 GBP2024-12-31
185,215 GBP2023-12-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
-3,643 GBP2024-12-31
-2,755 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000 shares2024-12-31
  • NEVRO MEDICAL LIMITED
    Info
    Registered number 07268550
    Fourth Floor St James House, St James' Square, Cheltenham GL50 3PR
    PRIVATE LIMITED COMPANY incorporated on 2010-05-28 (16 years). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-05-28
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.